Severe Kidney Involvement and Therapeutic Gaps in Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Mexican Tertiary-Center Cohort (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0670; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Methylprednisolone pulses were administered in 34/38 (89.5%), cyclophosphamide in 31/40 (77.5%), and rituximab in 2/36 (5.6%). Conclusion This Mexican tertiary-center cohort showed severe renal disease at diagnosis, MPO-ANCA predominance, frequent dialysis requirement, and chronic histopathologic damage. Despite broad indication for plasma exchange, access was limited, suggesting delayed referral and need for earlier diagnosis."
ANCA Vasculitis • Cardiovascular • Diabetes • Diabetic Nephropathy • Hypertension • Infectious Disease • Metabolic Disorders • Nephrology • Renal Disease • Type 2 Diabetes Mellitus • Vasculitis
|
|
Karen Guadalupe Rodriguez Alvarez; Pablo E. Galindo; Sofía Velázquez De La Paz; L. Monserrat Perez-Navarro; David E. Prestegui; Angela Maria Cordoba Hurtado
|